Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin-dependent kinase-related kinase 2 (EtCRK2) is a cyclin-dependent kinase (CDK) identified in the apicomplexan parasite Eimeria tenella. It is closely related to eukaryotic CDKs, which are serine/threonine protein kinases that regulate cell cycle progression. EtCRK2 plays a critical role in regulating the cell cycle during both asexual and sexual stages of E. tenella's life cycle. It requires association with specific cyclins for full activation. Given its central role in parasite replication and development—and its divergence from host kinases—EtCRK2 represents an attractive target for anti-coccidial drug discovery efforts.
Inhibition of kinase activity to disrupt cell cycle progression and parasite replication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase-related kinase 2 (EtCRK2).